Abstract
Introduction/BackgroundIn patients treated for clinical early stage vulvar squamous cell carcinoma (VSCC), recurrence rate is reported to be up to 37%. Identification of prognostic factors related to recurrence and survival...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have